| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uterus | 103 | 2025 | 541 | 12.850 |
Why?
|
| Endometrium | 57 | 2026 | 292 | 12.750 |
Why?
|
| Receptors, Progesterone | 82 | 2025 | 677 | 11.510 |
Why?
|
| Embryo Implantation | 62 | 2025 | 218 | 9.370 |
Why?
|
| Progesterone | 68 | 2025 | 439 | 8.360 |
Why?
|
| Decidua | 41 | 2026 | 143 | 5.880 |
Why?
|
| Stromal Cells | 37 | 2026 | 316 | 5.840 |
Why?
|
| Estrogen Receptor alpha | 26 | 2025 | 431 | 4.320 |
Why?
|
| Mice | 319 | 2026 | 18301 | 3.600 |
Why?
|
| Gene Expression Regulation | 64 | 2021 | 2323 | 3.280 |
Why?
|
| Animals | 346 | 2026 | 33912 | 3.030 |
Why?
|
| Pregnancy | 100 | 2025 | 7512 | 2.900 |
Why?
|
| Transcriptome | 20 | 2025 | 1103 | 2.880 |
Why?
|
| Myometrium | 11 | 2025 | 47 | 2.750 |
Why?
|
| Integrases | 21 | 2025 | 157 | 2.720 |
Why?
|
| Uteroglobin | 26 | 2014 | 43 | 2.690 |
Why?
|
| Estrogens | 25 | 2025 | 434 | 2.670 |
Why?
|
| Mice, Transgenic | 116 | 2025 | 2326 | 2.600 |
Why?
|
| Mice, Knockout | 115 | 2025 | 3819 | 2.560 |
Why?
|
| Epithelial Cells | 38 | 2025 | 905 | 2.550 |
Why?
|
| Signal Transduction | 67 | 2025 | 4686 | 2.520 |
Why?
|
| Fertility | 23 | 2020 | 260 | 2.410 |
Why?
|
| Transcription Factors | 39 | 2025 | 2406 | 2.080 |
Why?
|
| Female | 253 | 2026 | 70963 | 2.020 |
Why?
|
| Lung Neoplasms | 26 | 2024 | 1545 | 1.960 |
Why?
|
| Chromatin | 8 | 2025 | 499 | 1.930 |
Why?
|
| Estradiol | 25 | 2025 | 460 | 1.930 |
Why?
|
| Endometriosis | 7 | 2025 | 176 | 1.690 |
Why?
|
| Endometrial Neoplasms | 9 | 2023 | 110 | 1.660 |
Why?
|
| Reproduction | 15 | 2021 | 210 | 1.630 |
Why?
|
| Nuclear Receptor Coactivator 2 | 17 | 2023 | 147 | 1.580 |
Why?
|
| Epithelium | 24 | 2024 | 335 | 1.570 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 10 | 2021 | 588 | 1.520 |
Why?
|
| PTEN Phosphohydrolase | 13 | 2024 | 252 | 1.510 |
Why?
|
| Organoids | 4 | 2025 | 305 | 1.490 |
Why?
|
| Infertility, Female | 16 | 2025 | 145 | 1.360 |
Why?
|
| Transcription, Genetic | 24 | 2025 | 1363 | 1.350 |
Why?
|
| Forkhead Box Protein O1 | 4 | 2020 | 99 | 1.340 |
Why?
|
| WNK Lysine-Deficient Protein Kinase 1 | 3 | 2020 | 14 | 1.290 |
Why?
|
| Gene Deletion | 19 | 2021 | 767 | 1.270 |
Why?
|
| Proteins | 18 | 2009 | 1006 | 1.270 |
Why?
|
| Enhancer Elements, Genetic | 6 | 2025 | 263 | 1.240 |
Why?
|
| Wnt Proteins | 12 | 2017 | 191 | 1.230 |
Why?
|
| Ovary | 26 | 2020 | 345 | 1.210 |
Why?
|
| Cell Proliferation | 39 | 2025 | 2465 | 1.210 |
Why?
|
| Lung | 23 | 2024 | 1535 | 1.200 |
Why?
|
| Models, Animal | 13 | 2025 | 450 | 1.140 |
Why?
|
| Promoter Regions, Genetic | 42 | 2025 | 1207 | 1.110 |
Why?
|
| Urogenital Abnormalities | 3 | 2020 | 155 | 1.080 |
Why?
|
| Humans | 167 | 2026 | 131163 | 1.030 |
Why?
|
| DNA-Binding Proteins | 27 | 2024 | 1939 | 1.030 |
Why?
|
| Mammary Glands, Animal | 28 | 2019 | 448 | 1.010 |
Why?
|
| Cell Transformation, Neoplastic | 10 | 2017 | 587 | 0.990 |
Why?
|
| Trans-Activators | 15 | 2023 | 697 | 0.990 |
Why?
|
| Hedgehog Proteins | 13 | 2018 | 199 | 0.970 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 7 | 2019 | 29 | 0.950 |
Why?
|
| Mice, Inbred C57BL | 58 | 2026 | 4738 | 0.940 |
Why?
|
| HMGB Proteins | 2 | 2018 | 8 | 0.940 |
Why?
|
| SOXF Transcription Factors | 2 | 2018 | 16 | 0.940 |
Why?
|
| Serum Response Factor | 1 | 2025 | 30 | 0.920 |
Why?
|
| COUP Transcription Factor II | 13 | 2023 | 99 | 0.920 |
Why?
|
| Receptors, Calcitriol | 1 | 2026 | 60 | 0.920 |
Why?
|
| Inflammation | 4 | 2025 | 1489 | 0.910 |
Why?
|
| Pregnancy, Animal | 6 | 2017 | 66 | 0.910 |
Why?
|
| Disease Models, Animal | 32 | 2021 | 4697 | 0.900 |
Why?
|
| Menstruation | 2 | 2023 | 28 | 0.900 |
Why?
|
| Respiratory Mucosa | 8 | 2008 | 93 | 0.900 |
Why?
|
| Histone Code | 1 | 2025 | 46 | 0.880 |
Why?
|
| Receptors, Transforming Growth Factor beta | 4 | 2023 | 111 | 0.870 |
Why?
|
| Vitamin D Deficiency | 1 | 2026 | 82 | 0.870 |
Why?
|
| Gene Expression Regulation, Developmental | 21 | 2021 | 950 | 0.860 |
Why?
|
| Morphogenesis | 12 | 2018 | 185 | 0.860 |
Why?
|
| Homeostasis | 9 | 2020 | 712 | 0.840 |
Why?
|
| Immunohistochemistry | 35 | 2018 | 1591 | 0.840 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 11 | 2014 | 318 | 0.820 |
Why?
|
| Embryo, Mammalian | 16 | 2022 | 403 | 0.820 |
Why?
|
| Histones | 6 | 2025 | 541 | 0.810 |
Why?
|
| Epigenesis, Genetic | 3 | 2026 | 757 | 0.810 |
Why?
|
| Ovarian Follicle | 6 | 2019 | 127 | 0.810 |
Why?
|
| Ovulation | 9 | 2019 | 102 | 0.800 |
Why?
|
| GATA2 Transcription Factor | 5 | 2018 | 46 | 0.790 |
Why?
|
| Recombinases | 1 | 2023 | 28 | 0.770 |
Why?
|
| Glucose Intolerance | 5 | 2021 | 80 | 0.760 |
Why?
|
| Genes, ras | 5 | 2017 | 95 | 0.740 |
Why?
|
| Prolactin | 2 | 2022 | 142 | 0.730 |
Why?
|
| Embryonic Development | 10 | 2025 | 200 | 0.730 |
Why?
|
| Cell Differentiation | 28 | 2020 | 1928 | 0.710 |
Why?
|
| Mice, Mutant Strains | 16 | 2021 | 356 | 0.710 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2019 | 597 | 0.700 |
Why?
|
| Gene Expression Regulation, Neoplastic | 21 | 2024 | 2026 | 0.690 |
Why?
|
| Receptors, Glucocorticoid | 4 | 2019 | 105 | 0.680 |
Why?
|
| Receptors, Estrogen | 5 | 2022 | 732 | 0.680 |
Why?
|
| Disease Progression | 11 | 2021 | 2200 | 0.680 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2017 | 619 | 0.680 |
Why?
|
| Carcinoma, Squamous Cell | 5 | 2021 | 750 | 0.670 |
Why?
|
| Fallopian Tubes | 5 | 2025 | 66 | 0.670 |
Why?
|
| Uterine Contraction | 1 | 2021 | 29 | 0.670 |
Why?
|
| Receptors, Oxytocin | 1 | 2021 | 20 | 0.670 |
Why?
|
| TRPC Cation Channels | 1 | 2021 | 19 | 0.670 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2020 | 480 | 0.660 |
Why?
|
| Forkhead Box Protein L2 | 1 | 2020 | 10 | 0.660 |
Why?
|
| Periodontal Diseases | 1 | 2021 | 31 | 0.660 |
Why?
|
| Cells, Cultured | 31 | 2022 | 2885 | 0.650 |
Why?
|
| Protein Phosphatase 2 | 1 | 2020 | 34 | 0.650 |
Why?
|
| Abortion, Spontaneous | 3 | 2021 | 81 | 0.650 |
Why?
|
| Smad4 Protein | 3 | 2019 | 59 | 0.640 |
Why?
|
| Pregnancy Proteins | 1 | 2019 | 17 | 0.620 |
Why?
|
| Biomarkers | 7 | 2021 | 3385 | 0.610 |
Why?
|
| Genetic Engineering | 8 | 2024 | 161 | 0.610 |
Why?
|
| Endometrial Hyperplasia | 3 | 2014 | 21 | 0.600 |
Why?
|
| Receptors, Somatostatin | 10 | 2012 | 55 | 0.590 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2019 | 18 | 0.590 |
Why?
|
| Receptors, Steroid | 8 | 2024 | 167 | 0.590 |
Why?
|
| Gene Expression Profiling | 20 | 2021 | 1801 | 0.590 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2019 | 13 | 0.590 |
Why?
|
| Binding Sites | 13 | 2020 | 1133 | 0.580 |
Why?
|
| Cell Cycle | 7 | 2024 | 594 | 0.570 |
Why?
|
| Mediator Complex | 1 | 2019 | 62 | 0.570 |
Why?
|
| Bone Morphogenetic Proteins | 6 | 2021 | 127 | 0.570 |
Why?
|
| Gene Regulatory Networks | 3 | 2020 | 373 | 0.560 |
Why?
|
| Parturition | 4 | 2022 | 65 | 0.560 |
Why?
|
| Homeodomain Proteins | 12 | 2020 | 555 | 0.560 |
Why?
|
| Chromatin Immunoprecipitation | 9 | 2015 | 223 | 0.560 |
Why?
|
| Base Sequence | 25 | 2019 | 2730 | 0.540 |
Why?
|
| RNA, Small Interfering | 10 | 2020 | 664 | 0.530 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2017 | 11 | 0.530 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 18 | 2015 | 992 | 0.520 |
Why?
|
| Insulin Resistance | 3 | 2025 | 690 | 0.520 |
Why?
|
| Apoptosis | 19 | 2020 | 1827 | 0.510 |
Why?
|
| Pregnancy Maintenance | 2 | 2014 | 5 | 0.510 |
Why?
|
| Placentation | 5 | 2017 | 59 | 0.510 |
Why?
|
| Tumor Suppressor Proteins | 6 | 2019 | 484 | 0.500 |
Why?
|
| Oviducts | 6 | 2025 | 99 | 0.500 |
Why?
|
| Muscle Proteins | 2 | 2019 | 401 | 0.500 |
Why?
|
| Genome, Human | 3 | 2019 | 1321 | 0.500 |
Why?
|
| Models, Biological | 18 | 2020 | 1371 | 0.500 |
Why?
|
| Gene Editing | 4 | 2024 | 238 | 0.490 |
Why?
|
| Carcinogenesis | 5 | 2023 | 336 | 0.490 |
Why?
|
| Protein Binding | 10 | 2020 | 1652 | 0.490 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 19 | 2013 | 1205 | 0.480 |
Why?
|
| Biology | 1 | 2016 | 24 | 0.480 |
Why?
|
| Cell Line | 19 | 2026 | 2552 | 0.480 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 4 | 2021 | 176 | 0.480 |
Why?
|
| Recombination, Genetic | 8 | 2022 | 422 | 0.480 |
Why?
|
| Neoplasm Proteins | 6 | 2024 | 680 | 0.470 |
Why?
|
| CRISPR-Cas Systems | 5 | 2024 | 317 | 0.470 |
Why?
|
| beta Catenin | 8 | 2016 | 197 | 0.470 |
Why?
|
| Infertility | 6 | 2019 | 76 | 0.470 |
Why?
|
| RNA Splicing Factors | 1 | 2016 | 51 | 0.470 |
Why?
|
| Receptors, Androgen | 4 | 2018 | 408 | 0.470 |
Why?
|
| ErbB Receptors | 3 | 2014 | 286 | 0.460 |
Why?
|
| Cell Line, Transformed | 6 | 2007 | 159 | 0.450 |
Why?
|
| Mifepristone | 14 | 2020 | 81 | 0.450 |
Why?
|
| Gene Targeting | 17 | 2012 | 169 | 0.440 |
Why?
|
| Transforming Growth Factor beta | 5 | 2020 | 451 | 0.440 |
Why?
|
| Forkhead Transcription Factors | 2 | 2015 | 371 | 0.440 |
Why?
|
| Premature Birth | 2 | 2017 | 428 | 0.430 |
Why?
|
| Interferon Regulatory Factors | 1 | 2015 | 46 | 0.430 |
Why?
|
| Insulin-Like Growth Factor I | 6 | 2021 | 324 | 0.430 |
Why?
|
| Epigenomics | 2 | 2026 | 181 | 0.420 |
Why?
|
| Cell Communication | 3 | 2017 | 188 | 0.420 |
Why?
|
| Nuclear Receptor Coactivator 1 | 8 | 2020 | 161 | 0.420 |
Why?
|
| Granulosa Cells | 9 | 2019 | 143 | 0.420 |
Why?
|
| Paracrine Communication | 2 | 2011 | 69 | 0.420 |
Why?
|
| Repressor Proteins | 9 | 2018 | 760 | 0.420 |
Why?
|
| Gene Expression | 21 | 2019 | 1481 | 0.410 |
Why?
|
| Adenocarcinoma | 8 | 2018 | 972 | 0.410 |
Why?
|
| Mammals | 4 | 2022 | 253 | 0.400 |
Why?
|
| Ovarian Neoplasms | 5 | 2020 | 420 | 0.390 |
Why?
|
| Nuclear Proteins | 8 | 2018 | 1211 | 0.390 |
Why?
|
| Male | 84 | 2025 | 64957 | 0.390 |
Why?
|
| RNA, Messenger | 33 | 2023 | 2550 | 0.390 |
Why?
|
| RNA Interference | 9 | 2020 | 491 | 0.390 |
Why?
|
| Placenta | 7 | 2017 | 504 | 0.390 |
Why?
|
| Pregnancy Complications | 3 | 2017 | 567 | 0.390 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 8 | 2010 | 288 | 0.370 |
Why?
|
| Pseudopregnancy | 6 | 2012 | 16 | 0.370 |
Why?
|
| Pneumonia | 3 | 2008 | 341 | 0.370 |
Why?
|
| Ovariectomy | 10 | 2013 | 152 | 0.370 |
Why?
|
| Islets of Langerhans | 10 | 2012 | 163 | 0.360 |
Why?
|
| Cumulus Cells | 5 | 2019 | 42 | 0.360 |
Why?
|
| Protein Isoforms | 8 | 2025 | 423 | 0.350 |
Why?
|
| Corpus Luteum | 5 | 2019 | 24 | 0.350 |
Why?
|
| Stem Cells | 9 | 2013 | 702 | 0.350 |
Why?
|
| Precancerous Conditions | 3 | 2010 | 281 | 0.340 |
Why?
|
| Mutation | 19 | 2024 | 6099 | 0.340 |
Why?
|
| Cell Nucleus | 7 | 2018 | 556 | 0.340 |
Why?
|
| Glycoproteins | 5 | 2024 | 346 | 0.340 |
Why?
|
| Luteinizing Hormone | 4 | 2020 | 118 | 0.330 |
Why?
|
| Carcinoma, Endometrioid | 3 | 2016 | 17 | 0.330 |
Why?
|
| Research | 1 | 2013 | 264 | 0.330 |
Why?
|
| Alleles | 10 | 2024 | 1673 | 0.330 |
Why?
|
| Cell Line, Tumor | 17 | 2024 | 3748 | 0.330 |
Why?
|
| Organ Specificity | 21 | 2019 | 394 | 0.330 |
Why?
|
| Prostatic Neoplasms | 10 | 2011 | 1419 | 0.330 |
Why?
|
| Fibrosis | 2 | 2025 | 429 | 0.320 |
Why?
|
| Antigens, Polyomavirus Transforming | 5 | 2007 | 84 | 0.320 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2019 | 289 | 0.320 |
Why?
|
| Insulin | 15 | 2012 | 1149 | 0.320 |
Why?
|
| Molecular Sequence Data | 23 | 2015 | 3464 | 0.310 |
Why?
|
| Databases, Genetic | 1 | 2013 | 504 | 0.310 |
Why?
|
| Liver | 11 | 2014 | 1796 | 0.310 |
Why?
|
| Fibroblast Growth Factors | 4 | 2011 | 172 | 0.310 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 3 | 2020 | 20 | 0.310 |
Why?
|
| RNA-Binding Proteins | 3 | 2021 | 533 | 0.300 |
Why?
|
| Epidermal Growth Factor | 1 | 2010 | 115 | 0.300 |
Why?
|
| DEAD-box RNA Helicases | 3 | 2020 | 160 | 0.290 |
Why?
|
| Oocytes | 9 | 2024 | 283 | 0.290 |
Why?
|
| Leukemia Inhibitory Factor | 5 | 2025 | 27 | 0.290 |
Why?
|
| Phosphorylation | 10 | 2021 | 1571 | 0.290 |
Why?
|
| In Situ Hybridization | 16 | 2010 | 437 | 0.290 |
Why?
|
| Glucose | 8 | 2015 | 853 | 0.290 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 5 | 2003 | 150 | 0.290 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2019 | 242 | 0.280 |
Why?
|
| Bone Morphogenetic Protein 2 | 4 | 2014 | 86 | 0.280 |
Why?
|
| Phenotype | 19 | 2024 | 4497 | 0.280 |
Why?
|
| Wnt4 Protein | 6 | 2017 | 23 | 0.280 |
Why?
|
| Interferon-gamma | 3 | 2005 | 544 | 0.280 |
Why?
|
| Mesoderm | 3 | 2011 | 106 | 0.280 |
Why?
|
| Hyperplasia | 10 | 2017 | 191 | 0.270 |
Why?
|
| Models, Genetic | 10 | 2010 | 749 | 0.270 |
Why?
|
| Blotting, Western | 13 | 2013 | 1013 | 0.270 |
Why?
|
| Down-Regulation | 8 | 2017 | 645 | 0.270 |
Why?
|
| Prostate | 7 | 2014 | 404 | 0.260 |
Why?
|
| Membrane Proteins | 7 | 2024 | 1590 | 0.260 |
Why?
|
| Genome | 4 | 2021 | 451 | 0.260 |
Why?
|
| Hormones | 5 | 2020 | 162 | 0.260 |
Why?
|
| Ribonuclease III | 3 | 2020 | 100 | 0.260 |
Why?
|
| Medroxyprogesterone Acetate | 2 | 2025 | 19 | 0.250 |
Why?
|
| Chromosomes, Artificial, Bacterial | 5 | 2012 | 87 | 0.250 |
Why?
|
| Muscle, Skeletal | 5 | 2025 | 981 | 0.250 |
Why?
|
| DNA Primers | 9 | 2009 | 599 | 0.240 |
Why?
|
| Fibroblasts | 5 | 2025 | 849 | 0.240 |
Why?
|
| Aging | 6 | 2017 | 1242 | 0.240 |
Why?
|
| Gene Silencing | 4 | 2013 | 229 | 0.240 |
Why?
|
| Caveolin 1 | 3 | 2011 | 51 | 0.240 |
Why?
|
| Protein Biosynthesis | 6 | 2003 | 569 | 0.240 |
Why?
|
| Wnt Signaling Pathway | 5 | 2014 | 223 | 0.240 |
Why?
|
| MicroRNAs | 7 | 2021 | 889 | 0.240 |
Why?
|
| Embryonic Stem Cells | 4 | 2018 | 157 | 0.240 |
Why?
|
| Rabbits | 9 | 2004 | 575 | 0.230 |
Why?
|
| Histone Acetyltransferases | 7 | 2009 | 226 | 0.230 |
Why?
|
| Chloride Channels | 1 | 2006 | 55 | 0.230 |
Why?
|
| Blastocyst | 8 | 2025 | 73 | 0.230 |
Why?
|
| Genetic Techniques | 4 | 2005 | 95 | 0.230 |
Why?
|
| Cdh1 Proteins | 3 | 2014 | 9 | 0.230 |
Why?
|
| Cytokines | 4 | 2017 | 1339 | 0.230 |
Why?
|
| Receptors, Peptide | 3 | 2023 | 60 | 0.230 |
Why?
|
| Vitamin D | 2 | 2026 | 194 | 0.230 |
Why?
|
| Tamoxifen | 2 | 2025 | 348 | 0.220 |
Why?
|
| Mitochondria, Muscle | 1 | 2025 | 37 | 0.220 |
Why?
|
| Cyclin A2 | 1 | 2024 | 4 | 0.220 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2017 | 128 | 0.220 |
Why?
|
| Menstrual Cycle | 2 | 2022 | 33 | 0.220 |
Why?
|
| Adult | 12 | 2021 | 31282 | 0.220 |
Why?
|
| Neovascularization, Physiologic | 3 | 2013 | 197 | 0.220 |
Why?
|
| Gene Knockdown Techniques | 4 | 2020 | 378 | 0.220 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2017 | 371 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2024 | 58 | 0.210 |
Why?
|
| Genes, Essential | 1 | 2024 | 39 | 0.210 |
Why?
|
| Genotype | 5 | 2021 | 2595 | 0.210 |
Why?
|
| Physical Conditioning, Animal | 1 | 2025 | 84 | 0.210 |
Why?
|
| Cloning, Molecular | 9 | 2017 | 780 | 0.210 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2015 | 639 | 0.210 |
Why?
|
| Genes, Reporter | 13 | 2012 | 341 | 0.210 |
Why?
|
| Animals, Newborn | 7 | 2017 | 1021 | 0.210 |
Why?
|
| Phosphoproteins | 4 | 2016 | 448 | 0.210 |
Why?
|
| Bronchi | 6 | 2011 | 98 | 0.200 |
Why?
|
| Cell Cycle Proteins | 6 | 2012 | 710 | 0.200 |
Why?
|
| Transgenes | 13 | 2012 | 316 | 0.200 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 1 | 2023 | 16 | 0.200 |
Why?
|
| Adaptation, Physiological | 1 | 2025 | 258 | 0.200 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 2 | 2014 | 41 | 0.200 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 2 | 2015 | 32 | 0.200 |
Why?
|
| Real-Time Polymerase Chain Reaction | 7 | 2013 | 526 | 0.190 |
Why?
|
| Frizzled Receptors | 3 | 2012 | 19 | 0.190 |
Why?
|
| Polymerase Chain Reaction | 8 | 2012 | 1447 | 0.190 |
Why?
|
| Fatty Acids | 1 | 2006 | 377 | 0.190 |
Why?
|
| NF-kappa B | 3 | 2017 | 440 | 0.190 |
Why?
|
| Membrane Glycoproteins | 6 | 2016 | 405 | 0.190 |
Why?
|
| Circadian Rhythm | 3 | 2014 | 327 | 0.190 |
Why?
|
| GATA6 Transcription Factor | 2 | 2015 | 10 | 0.190 |
Why?
|
| Viral Proteins | 7 | 2003 | 337 | 0.190 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2021 | 94 | 0.190 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2021 | 170 | 0.180 |
Why?
|
| Mammary Glands, Human | 4 | 2007 | 79 | 0.180 |
Why?
|
| Glycolysis | 2 | 2020 | 174 | 0.180 |
Why?
|
| Carcinoma | 4 | 2013 | 291 | 0.180 |
Why?
|
| Follicle Stimulating Hormone | 4 | 2019 | 175 | 0.180 |
Why?
|
| Molecular Sequence Annotation | 2 | 2013 | 146 | 0.180 |
Why?
|
| Nuclear Receptor Coactivators | 3 | 2012 | 64 | 0.180 |
Why?
|
| Muscle Contraction | 1 | 2022 | 147 | 0.180 |
Why?
|
| Metabolome | 3 | 2018 | 326 | 0.180 |
Why?
|
| Recombinant Proteins | 12 | 2019 | 1319 | 0.170 |
Why?
|
| Gene Transfer Techniques | 3 | 2012 | 344 | 0.170 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2008 | 650 | 0.170 |
Why?
|
| Killer Cells, Natural | 2 | 2022 | 355 | 0.170 |
Why?
|
| Mice, 129 Strain | 4 | 2019 | 96 | 0.170 |
Why?
|
| Molecular Chaperones | 4 | 2015 | 172 | 0.170 |
Why?
|
| Early Growth Response Protein 1 | 2 | 2019 | 38 | 0.170 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 35 | 0.170 |
Why?
|
| Clomiphene | 1 | 2021 | 15 | 0.170 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2021 | 62 | 0.170 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2017 | 986 | 0.170 |
Why?
|
| Metaplasia | 4 | 2016 | 215 | 0.170 |
Why?
|
| Cell Lineage | 3 | 2008 | 349 | 0.170 |
Why?
|
| Pulmonary Alveoli | 5 | 2008 | 139 | 0.170 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2002 | 82 | 0.170 |
Why?
|
| Vaginal Neoplasms | 1 | 2021 | 17 | 0.170 |
Why?
|
| Litter Size | 2 | 2019 | 24 | 0.170 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 2 | 2018 | 12 | 0.160 |
Why?
|
| Response Elements | 4 | 2019 | 102 | 0.160 |
Why?
|
| Kruppel-Like Transcription Factors | 3 | 2016 | 111 | 0.160 |
Why?
|
| Choristoma | 3 | 2013 | 43 | 0.160 |
Why?
|
| Interleukin-13 Receptor alpha2 Subunit | 1 | 2020 | 20 | 0.160 |
Why?
|
| Leukemia | 1 | 2024 | 387 | 0.160 |
Why?
|
| RANK Ligand | 3 | 2010 | 51 | 0.160 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2020 | 50 | 0.160 |
Why?
|
| BRCA1 Protein | 1 | 2020 | 78 | 0.160 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2000 | 37 | 0.160 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2020 | 25 | 0.160 |
Why?
|
| Pituitary Gland, Anterior | 2 | 2019 | 17 | 0.160 |
Why?
|
| Prostatic Hyperplasia | 4 | 2009 | 110 | 0.160 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 1 | 2020 | 10 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2011 | 188 | 0.160 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2020 | 167 | 0.160 |
Why?
|
| Cell Polarity | 2 | 2018 | 117 | 0.160 |
Why?
|
| Deoxyglucose | 1 | 2020 | 41 | 0.160 |
Why?
|
| Fetal Growth Retardation | 5 | 2015 | 253 | 0.160 |
Why?
|
| Crosses, Genetic | 8 | 2010 | 152 | 0.150 |
Why?
|
| Transfection | 9 | 2007 | 962 | 0.150 |
Why?
|
| Recombinant Fusion Proteins | 8 | 2009 | 688 | 0.150 |
Why?
|
| beta-Galactosidase | 8 | 2011 | 135 | 0.150 |
Why?
|
| Autophagy-Related Proteins | 1 | 2020 | 37 | 0.150 |
Why?
|
| Developmental Biology | 1 | 2019 | 10 | 0.150 |
Why?
|
| Blotting, Northern | 7 | 2009 | 234 | 0.150 |
Why?
|
| Somatostatin | 3 | 2012 | 60 | 0.150 |
Why?
|
| Green Fluorescent Proteins | 4 | 2024 | 358 | 0.150 |
Why?
|
| Aromatase | 3 | 2018 | 23 | 0.150 |
Why?
|
| Muscle, Smooth | 2 | 2014 | 116 | 0.150 |
Why?
|
| Mitochondria | 1 | 2025 | 785 | 0.150 |
Why?
|
| Glomerulonephritis | 1 | 2000 | 74 | 0.150 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2019 | 12 | 0.150 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 81 | 0.150 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2023 | 254 | 0.150 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2019 | 69 | 0.150 |
Why?
|
| Nucleotide Motifs | 2 | 2019 | 51 | 0.150 |
Why?
|
| Receptors, Cell Surface | 6 | 2014 | 420 | 0.150 |
Why?
|
| Antigens, Viral, Tumor | 3 | 1996 | 43 | 0.140 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 3 | 2006 | 35 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2013 | 325 | 0.140 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2019 | 71 | 0.140 |
Why?
|
| Abdominal Muscles | 1 | 2018 | 28 | 0.140 |
Why?
|
| Aldose-Ketose Isomerases | 1 | 2018 | 9 | 0.140 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2018 | 43 | 0.140 |
Why?
|
| Proteome | 1 | 2020 | 285 | 0.140 |
Why?
|
| Cell Transformation, Viral | 2 | 2007 | 96 | 0.140 |
Why?
|
| Hernia, Inguinal | 1 | 2018 | 40 | 0.140 |
Why?
|
| Wound Healing | 1 | 2002 | 490 | 0.140 |
Why?
|
| Embryonic and Fetal Development | 7 | 2003 | 117 | 0.140 |
Why?
|
| Pancreas | 7 | 2012 | 217 | 0.140 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2019 | 67 | 0.140 |
Why?
|
| Cell Movement | 3 | 2018 | 876 | 0.140 |
Why?
|
| Rats | 14 | 2006 | 3370 | 0.140 |
Why?
|
| Cardiomegaly | 3 | 2004 | 117 | 0.140 |
Why?
|
| Transcriptional Activation | 3 | 2019 | 419 | 0.140 |
Why?
|
| Microtubule Proteins | 2 | 2009 | 28 | 0.140 |
Why?
|
| Hypothalamus | 2 | 2019 | 206 | 0.140 |
Why?
|
| Regeneration | 4 | 2013 | 230 | 0.140 |
Why?
|
| DNA, Single-Stranded | 1 | 2018 | 69 | 0.140 |
Why?
|
| Genitalia, Female | 3 | 2008 | 44 | 0.130 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2018 | 109 | 0.130 |
Why?
|
| Up-Regulation | 7 | 2020 | 825 | 0.130 |
Why?
|
| Periodontitis | 1 | 2018 | 19 | 0.130 |
Why?
|
| Hyperoxia | 1 | 2000 | 136 | 0.130 |
Why?
|
| Receptor, ErbB-4 | 1 | 2017 | 6 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2018 | 2833 | 0.130 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 350 | 0.130 |
Why?
|
| Muscular Atrophy | 1 | 2018 | 84 | 0.130 |
Why?
|
| Macrophages | 3 | 2020 | 667 | 0.130 |
Why?
|
| Corpus Luteum Maintenance | 1 | 2017 | 3 | 0.130 |
Why?
|
| Luteal Cells | 1 | 2017 | 8 | 0.130 |
Why?
|
| Neovascularization, Pathologic | 3 | 2014 | 227 | 0.130 |
Why?
|
| Young Adult | 5 | 2020 | 10103 | 0.130 |
Why?
|
| Carrier Proteins | 4 | 2015 | 993 | 0.130 |
Why?
|
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2017 | 6 | 0.130 |
Why?
|
| ARNTL Transcription Factors | 2 | 2014 | 45 | 0.130 |
Why?
|
| Interleukin-17 | 1 | 2018 | 125 | 0.130 |
Why?
|
| Abnormalities, Multiple | 2 | 2016 | 963 | 0.130 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 2904 | 0.130 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 819 | 0.130 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2017 | 22 | 0.130 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2017 | 25 | 0.130 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2017 | 43 | 0.130 |
Why?
|
| Xenopus Proteins | 3 | 2003 | 55 | 0.130 |
Why?
|
| Receptors, OSM-LIF | 1 | 2017 | 6 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2017 | 1071 | 0.130 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2015 | 125 | 0.130 |
Why?
|
| Exons | 5 | 2018 | 759 | 0.130 |
Why?
|
| Cell Division | 12 | 2006 | 718 | 0.130 |
Why?
|
| Celiac Disease | 1 | 2018 | 73 | 0.130 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 66 | 0.130 |
Why?
|
| Insulinoma | 3 | 2012 | 8 | 0.130 |
Why?
|
| Cell Transdifferentiation | 1 | 2017 | 57 | 0.120 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 177 | 0.120 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 236 | 0.120 |
Why?
|
| GATA4 Transcription Factor | 2 | 2015 | 35 | 0.120 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1996 | 20 | 0.120 |
Why?
|
| src-Family Kinases | 1 | 2017 | 92 | 0.120 |
Why?
|
| Spermatozoa | 6 | 2009 | 254 | 0.120 |
Why?
|
| Nuclear Receptor Coactivator 3 | 3 | 2007 | 257 | 0.120 |
Why?
|
| Autophagy | 1 | 2020 | 417 | 0.120 |
Why?
|
| Enzyme Inhibitors | 5 | 2004 | 573 | 0.120 |
Why?
|
| Junctional Adhesion Molecule B | 1 | 2016 | 4 | 0.120 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2016 | 13 | 0.120 |
Why?
|
| Myocardium | 7 | 2006 | 852 | 0.120 |
Why?
|
| Mice, Inbred ICR | 10 | 2003 | 138 | 0.120 |
Why?
|
| Ligands | 5 | 2005 | 481 | 0.120 |
Why?
|
| Consensus Sequence | 2 | 2014 | 54 | 0.120 |
Why?
|
| Conserved Sequence | 1 | 2016 | 277 | 0.120 |
Why?
|
| Awareness | 1 | 2016 | 78 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 2 | 2018 | 407 | 0.120 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2015 | 10 | 0.120 |
Why?
|
| Testis | 7 | 2008 | 389 | 0.120 |
Why?
|
| Luteinization | 1 | 2015 | 12 | 0.120 |
Why?
|
| Reproductive Health | 1 | 2016 | 48 | 0.120 |
Why?
|
| Body Weight | 3 | 2015 | 987 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 2 | 2012 | 740 | 0.110 |
Why?
|
| Corticomedial Nuclear Complex | 1 | 2015 | 3 | 0.110 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2014 | 722 | 0.110 |
Why?
|
| Keratin-8 | 2 | 2012 | 12 | 0.110 |
Why?
|
| Fos-Related Antigen-2 | 1 | 2015 | 4 | 0.110 |
Why?
|
| Adolescent | 6 | 2020 | 20987 | 0.110 |
Why?
|
| Estrogen Receptor beta | 1 | 2015 | 87 | 0.110 |
Why?
|
| Chorionic Gonadotropin | 5 | 2015 | 76 | 0.110 |
Why?
|
| Survival Rate | 2 | 2019 | 2114 | 0.110 |
Why?
|
| Analysis of Variance | 4 | 2010 | 928 | 0.110 |
Why?
|
| Placental Insufficiency | 1 | 2015 | 14 | 0.110 |
Why?
|
| Heme Oxygenase-1 | 1 | 2015 | 33 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 6 | 2020 | 975 | 0.110 |
Why?
|
| Progestins | 3 | 2016 | 39 | 0.110 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2015 | 65 | 0.110 |
Why?
|
| p21-Activated Kinases | 1 | 2015 | 57 | 0.110 |
Why?
|
| Neuropeptides | 1 | 2015 | 106 | 0.110 |
Why?
|
| Chemokine CXCL5 | 1 | 2014 | 7 | 0.110 |
Why?
|
| Transcription Factor AP-1 | 1 | 2015 | 110 | 0.110 |
Why?
|
| Mammary Tumor Virus, Mouse | 3 | 2010 | 100 | 0.110 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 3829 | 0.110 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2014 | 14 | 0.110 |
Why?
|
| Receptor, ErbB-3 | 1 | 2014 | 24 | 0.110 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2014 | 37 | 0.110 |
Why?
|
| Microarray Analysis | 3 | 2012 | 222 | 0.110 |
Why?
|
| Health Education | 1 | 2016 | 228 | 0.110 |
Why?
|
| Receptors, Notch | 2 | 2014 | 197 | 0.100 |
Why?
|
| Retinoblastoma Protein | 2 | 2013 | 78 | 0.100 |
Why?
|
| Gonadal Steroid Hormones | 3 | 2021 | 82 | 0.100 |
Why?
|
| Mammary Neoplasms, Animal | 3 | 2007 | 135 | 0.100 |
Why?
|
| ADAM Proteins | 2 | 2011 | 78 | 0.100 |
Why?
|
| Diet | 1 | 2021 | 1121 | 0.100 |
Why?
|
| Inflammasomes | 1 | 2015 | 154 | 0.100 |
Why?
|
| Heat-Shock Proteins | 1 | 2015 | 174 | 0.100 |
Why?
|
| DNA Transposable Elements | 1 | 2015 | 178 | 0.100 |
Why?
|
| Testosterone | 2 | 2018 | 531 | 0.100 |
Why?
|
| Serine | 1 | 2014 | 161 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 789 | 0.100 |
Why?
|
| cdc25 Phosphatases | 2 | 2007 | 19 | 0.100 |
Why?
|
| Fetal Development | 1 | 2015 | 121 | 0.100 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2014 | 41 | 0.100 |
Why?
|
| Phosphofructokinase-2 | 1 | 2013 | 22 | 0.100 |
Why?
|
| Bronchioles | 2 | 2012 | 2 | 0.100 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2014 | 88 | 0.100 |
Why?
|
| Activin Receptors, Type I | 1 | 2013 | 34 | 0.100 |
Why?
|
| Dexamethasone | 2 | 2014 | 250 | 0.100 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 552 | 0.100 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2013 | 15 | 0.100 |
Why?
|
| Circadian Clocks | 1 | 2014 | 84 | 0.100 |
Why?
|
| Histone Deacetylase 2 | 1 | 2013 | 15 | 0.100 |
Why?
|
| Histone Deacetylase 1 | 1 | 2013 | 20 | 0.100 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2014 | 105 | 0.100 |
Why?
|
| Endoderm | 1 | 2013 | 24 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2013 | 42 | 0.100 |
Why?
|
| Growth Substances | 2 | 2004 | 99 | 0.100 |
Why?
|
| Mice, Inbred BALB C | 5 | 2019 | 978 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 3 | 2015 | 981 | 0.090 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2013 | 57 | 0.090 |
Why?
|
| Middle Aged | 6 | 2020 | 28601 | 0.090 |
Why?
|
| Mucoproteins | 1 | 2012 | 10 | 0.090 |
Why?
|
| Nodal Protein | 1 | 2012 | 28 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2009 | 300 | 0.090 |
Why?
|
| Promegestone | 1 | 2012 | 21 | 0.090 |
Why?
|
| Uterine Neoplasms | 1 | 2013 | 100 | 0.090 |
Why?
|
| Steroids | 4 | 2024 | 170 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2015 | 463 | 0.090 |
Why?
|
| COUP Transcription Factors | 4 | 2005 | 30 | 0.090 |
Why?
|
| MSX1 Transcription Factor | 1 | 2011 | 13 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2014 | 348 | 0.090 |
Why?
|
| Cell Death | 4 | 2019 | 224 | 0.090 |
Why?
|
| Sheep | 2 | 2019 | 229 | 0.090 |
Why?
|
| Tuberous Sclerosis | 1 | 2013 | 147 | 0.090 |
Why?
|
| Streptococcus pneumoniae | 1 | 2014 | 389 | 0.090 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2011 | 21 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 3 | 2011 | 1075 | 0.090 |
Why?
|
| Kidney Medulla | 1 | 2011 | 18 | 0.090 |
Why?
|
| Receptors, Drug | 2 | 2002 | 27 | 0.090 |
Why?
|
| Procollagen N-Endopeptidase | 1 | 2011 | 10 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 6797 | 0.090 |
Why?
|
| Chemokines | 2 | 2008 | 126 | 0.080 |
Why?
|
| Computational Biology | 3 | 2018 | 862 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2012 | 1618 | 0.080 |
Why?
|
| Biomedical Research | 1 | 2017 | 561 | 0.080 |
Why?
|
| Mullerian Ducts | 1 | 2011 | 44 | 0.080 |
Why?
|
| Air Pollutants | 1 | 2012 | 124 | 0.080 |
Why?
|
| Biomarkers, Tumor | 4 | 2020 | 1586 | 0.080 |
Why?
|
| Genetic Vectors | 7 | 2008 | 892 | 0.080 |
Why?
|
| Breast | 2 | 2020 | 215 | 0.080 |
Why?
|
| Zona Pellucida | 4 | 2003 | 11 | 0.080 |
Why?
|
| Estrous Cycle | 4 | 2016 | 40 | 0.080 |
Why?
|
| Exocrine Glands | 1 | 2010 | 6 | 0.080 |
Why?
|
| Cyclooxygenase 2 | 2 | 2008 | 121 | 0.080 |
Why?
|
| Potassium Channels | 2 | 2002 | 154 | 0.080 |
Why?
|
| Ovum | 3 | 1991 | 14 | 0.080 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2009 | 254 | 0.080 |
Why?
|
| Smoothened Receptor | 1 | 2010 | 31 | 0.080 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2013 | 269 | 0.080 |
Why?
|
| Genes, cdc | 1 | 2010 | 23 | 0.080 |
Why?
|
| Bile Acids and Salts | 1 | 2012 | 262 | 0.080 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2002 | 194 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2015 | 536 | 0.080 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2010 | 52 | 0.080 |
Why?
|
| Homozygote | 6 | 2012 | 533 | 0.080 |
Why?
|
| Glomerulonephritis, IGA | 2 | 2000 | 17 | 0.080 |
Why?
|
| Restriction Mapping | 4 | 2002 | 167 | 0.080 |
Why?
|
| Mucins | 2 | 2013 | 71 | 0.080 |
Why?
|
| Software | 1 | 2015 | 733 | 0.080 |
Why?
|
| Oncogene Proteins | 3 | 2012 | 136 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2008 | 335 | 0.080 |
Why?
|
| Cholesterol | 1 | 2012 | 539 | 0.080 |
Why?
|
| Protein Array Analysis | 1 | 2010 | 104 | 0.070 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2013 | 37 | 0.070 |
Why?
|
| Myosin Heavy Chains | 4 | 2005 | 74 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 2 | 2009 | 258 | 0.070 |
Why?
|
| Species Specificity | 5 | 2016 | 470 | 0.070 |
Why?
|
| Trophoblasts | 3 | 2020 | 113 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 3 | 2020 | 303 | 0.070 |
Why?
|
| Neoplasms, Experimental | 3 | 2020 | 201 | 0.070 |
Why?
|
| Genes | 3 | 2004 | 308 | 0.070 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 2002 | 222 | 0.070 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2008 | 10 | 0.070 |
Why?
|
| Porins | 1 | 2008 | 37 | 0.070 |
Why?
|
| Aerosols | 1 | 2008 | 57 | 0.070 |
Why?
|
| Oncogenes | 2 | 2000 | 164 | 0.070 |
Why?
|
| Sperm Motility | 1 | 2009 | 113 | 0.070 |
Why?
|
| Gap Junctions | 1 | 2008 | 41 | 0.070 |
Why?
|
| Endothelial Cells | 2 | 2009 | 523 | 0.070 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2008 | 152 | 0.070 |
Why?
|
| Actins | 4 | 1998 | 321 | 0.070 |
Why?
|
| Skin | 3 | 2010 | 545 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 359 | 0.070 |
Why?
|
| Neoplasm Metastasis | 3 | 2018 | 713 | 0.070 |
Why?
|
| Kidney Glomerulus | 2 | 1999 | 81 | 0.070 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2000 | 161 | 0.070 |
Why?
|
| Cytoplasm | 3 | 2003 | 249 | 0.070 |
Why?
|
| Time Factors | 9 | 2012 | 6196 | 0.070 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 4 | 1996 | 61 | 0.070 |
Why?
|
| Genetic Therapy | 2 | 2003 | 713 | 0.070 |
Why?
|
| Uterine Diseases | 1 | 2008 | 22 | 0.070 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2010 | 354 | 0.070 |
Why?
|
| Tumor Burden | 1 | 2008 | 240 | 0.070 |
Why?
|
| Endoribonucleases | 1 | 2008 | 87 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 2 | 2012 | 1692 | 0.070 |
Why?
|
| Fibroblast Growth Factor 3 | 3 | 2002 | 9 | 0.070 |
Why?
|
| Period Circadian Proteins | 2 | 2020 | 26 | 0.070 |
Why?
|
| Embryo Implantation, Delayed | 1 | 2007 | 5 | 0.070 |
Why?
|
| Patched Receptors | 2 | 2009 | 27 | 0.070 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2007 | 235 | 0.070 |
Why?
|
| Tetracycline | 1 | 2007 | 74 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 4 | 2012 | 119 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2008 | 88 | 0.070 |
Why?
|
| Patched-1 Receptor | 2 | 2009 | 38 | 0.060 |
Why?
|
| Genes, p53 | 2 | 2008 | 208 | 0.060 |
Why?
|
| Animals, Genetically Modified | 3 | 2024 | 291 | 0.060 |
Why?
|
| Tissue Culture Techniques | 1 | 2007 | 63 | 0.060 |
Why?
|
| Mutation, Missense | 3 | 2023 | 919 | 0.060 |
Why?
|
| Carcinoma, Small Cell | 1 | 2007 | 37 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 3 | 2004 | 235 | 0.060 |
Why?
|
| Ovulation Induction | 1 | 2007 | 38 | 0.060 |
Why?
|
| Asthenozoospermia | 1 | 2007 | 6 | 0.060 |
Why?
|
| Zygote | 2 | 2024 | 28 | 0.060 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2007 | 68 | 0.060 |
Why?
|
| Homeobox Protein Nkx-2.5 | 4 | 2003 | 20 | 0.060 |
Why?
|
| DNA | 6 | 2006 | 1399 | 0.060 |
Why?
|
| Pituitary Gland | 3 | 2020 | 74 | 0.060 |
Why?
|
| Ubiquitination | 3 | 2012 | 173 | 0.060 |
Why?
|
| Histidine Decarboxylase | 1 | 2006 | 12 | 0.060 |
Why?
|
| Placenta Diseases | 1 | 2007 | 55 | 0.060 |
Why?
|
| Aged | 3 | 2020 | 21025 | 0.060 |
Why?
|
| Energy Metabolism | 2 | 2015 | 804 | 0.060 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2006 | 18 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 2 | 2004 | 223 | 0.060 |
Why?
|
| Andersen Syndrome | 1 | 2006 | 5 | 0.060 |
Why?
|
| Cattle | 2 | 2004 | 501 | 0.060 |
Why?
|
| E-Box Elements | 1 | 2006 | 2 | 0.060 |
Why?
|
| Swine | 3 | 2004 | 1186 | 0.060 |
Why?
|
| Amino Acid Sequence | 6 | 2007 | 2395 | 0.060 |
Why?
|
| Gene Knockout Techniques | 2 | 2020 | 133 | 0.060 |
Why?
|
| Glycogen | 1 | 2006 | 50 | 0.060 |
Why?
|
| RNA, Untranslated | 2 | 2003 | 109 | 0.060 |
Why?
|
| Genes, Homeobox | 2 | 2011 | 61 | 0.060 |
Why?
|
| International Cooperation | 2 | 2021 | 165 | 0.060 |
Why?
|
| Mutagenesis | 3 | 2021 | 324 | 0.060 |
Why?
|
| Muscle Development | 2 | 2004 | 72 | 0.060 |
Why?
|
| Stomach | 2 | 2005 | 274 | 0.060 |
Why?
|
| Osteocalcin | 2 | 1997 | 46 | 0.060 |
Why?
|
| Interleukin-4 | 1 | 2005 | 144 | 0.060 |
Why?
|
| Retinoic Acid 4-Hydroxylase | 1 | 2005 | 4 | 0.060 |
Why?
|
| Ventricular Myosins | 1 | 2005 | 3 | 0.060 |
Why?
|
| Interleukin-13 | 1 | 2005 | 97 | 0.060 |
Why?
|
| Genomic Instability | 1 | 2007 | 245 | 0.060 |
Why?
|
| Enzymes | 1 | 2005 | 44 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2008 | 1483 | 0.050 |
Why?
|
| Fetal Death | 4 | 2012 | 115 | 0.050 |
Why?
|
| Veins | 1 | 2005 | 95 | 0.050 |
Why?
|
| Body Patterning | 1 | 2005 | 122 | 0.050 |
Why?
|
| Guinea Pigs | 1 | 2004 | 147 | 0.050 |
Why?
|
| rab3 GTP-Binding Proteins | 2 | 2004 | 7 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2004 | 76 | 0.050 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2005 | 104 | 0.050 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 2004 | 32 | 0.050 |
Why?
|
| Drosophila Proteins | 2 | 2000 | 718 | 0.050 |
Why?
|
| Primates | 1 | 2004 | 82 | 0.050 |
Why?
|
| Extremities | 1 | 2004 | 73 | 0.050 |
Why?
|
| Mice, Inbred Strains | 5 | 2007 | 263 | 0.050 |
Why?
|
| Hyperinsulinism | 1 | 2004 | 58 | 0.050 |
Why?
|
| Androgen-Binding Protein | 3 | 2009 | 20 | 0.050 |
Why?
|
| Interleukins | 1 | 2025 | 122 | 0.050 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2004 | 73 | 0.050 |
Why?
|
| Genomics | 2 | 2018 | 1621 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2007 | 623 | 0.050 |
Why?
|
| Genes, Switch | 1 | 2004 | 8 | 0.050 |
Why?
|
| Exocytosis | 1 | 2004 | 65 | 0.050 |
Why?
|
| Pregnancy Outcome | 2 | 2021 | 623 | 0.050 |
Why?
|
| Calcitonin | 1 | 2004 | 27 | 0.050 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2003 | 34 | 0.050 |
Why?
|
| 5' Flanking Region | 1 | 2003 | 8 | 0.050 |
Why?
|
| Fibronectins | 3 | 2000 | 99 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2003 | 33 | 0.050 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2023 | 20 | 0.050 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2023 | 18 | 0.050 |
Why?
|
| Antigens, Differentiation | 1 | 2003 | 63 | 0.050 |
Why?
|
| Zinc Fingers | 1 | 2024 | 116 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2025 | 233 | 0.050 |
Why?
|
| Glucagon-Like Peptide 1 | 2 | 2015 | 77 | 0.050 |
Why?
|
| Bone Morphogenetic Protein 15 | 4 | 2006 | 44 | 0.050 |
Why?
|
| Neoplasm Transplantation | 3 | 2012 | 358 | 0.050 |
Why?
|
| Heart Conduction System | 1 | 2004 | 164 | 0.050 |
Why?
|
| Triglycerides | 1 | 2006 | 602 | 0.050 |
Why?
|
| Growth Differentiation Factor 9 | 4 | 2006 | 50 | 0.050 |
Why?
|
| Mitosis | 2 | 2003 | 191 | 0.050 |
Why?
|
| Heterochromatin | 1 | 2003 | 52 | 0.050 |
Why?
|
| Cell Nucleolus | 1 | 2003 | 48 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 165 | 0.050 |
Why?
|
| RNA, Antisense | 2 | 2000 | 32 | 0.050 |
Why?
|
| Internet | 2 | 2021 | 420 | 0.050 |
Why?
|
| Protein Transport | 3 | 2011 | 366 | 0.050 |
Why?
|
| Sexual Maturation | 3 | 2013 | 45 | 0.050 |
Why?
|
| Adherens Junctions | 2 | 2013 | 17 | 0.050 |
Why?
|
| Bacterial Proteins | 1 | 2008 | 953 | 0.050 |
Why?
|
| Muscles | 2 | 1995 | 197 | 0.050 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2002 | 39 | 0.050 |
Why?
|
| Glucose Tolerance Test | 3 | 2012 | 198 | 0.050 |
Why?
|
| Serum Amyloid P-Component | 1 | 2002 | 14 | 0.050 |
Why?
|
| Guanine Nucleotide Dissociation Inhibitors | 1 | 2002 | 10 | 0.050 |
Why?
|
| Lac Operon | 4 | 2005 | 88 | 0.050 |
Why?
|
| Stereoisomerism | 1 | 2002 | 106 | 0.050 |
Why?
|
| Cyclins | 1 | 2002 | 94 | 0.050 |
Why?
|
| DNA, Complementary | 3 | 2003 | 422 | 0.050 |
Why?
|
| Wolffian Ducts | 1 | 2002 | 10 | 0.050 |
Why?
|
| Nerve Regeneration | 1 | 2002 | 69 | 0.050 |
Why?
|
| Horses | 1 | 2022 | 94 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 6 | 1 | 2021 | 6 | 0.040 |
Why?
|
| Immune Sera | 1 | 1981 | 54 | 0.040 |
Why?
|
| Immunoglobulin A | 2 | 2000 | 201 | 0.040 |
Why?
|
| Contraceptive Agents | 1 | 1981 | 13 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2002 | 131 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2001 | 14 | 0.040 |
Why?
|
| ADAMTS1 Protein | 2 | 2011 | 15 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2005 | 1117 | 0.040 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2002 | 71 | 0.040 |
Why?
|
| Activin Receptors, Type II | 1 | 2021 | 30 | 0.040 |
Why?
|
| Smad5 Protein | 1 | 2021 | 20 | 0.040 |
Why?
|
| A549 Cells | 1 | 2021 | 47 | 0.040 |
Why?
|
| Smad1 Protein | 1 | 2021 | 23 | 0.040 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 1287 | 0.040 |
Why?
|
| Adipose Tissue, Brown | 1 | 2001 | 89 | 0.040 |
Why?
|
| Limb Buds | 1 | 2001 | 5 | 0.040 |
Why?
|
| Heterozygote | 4 | 2012 | 737 | 0.040 |
Why?
|
| Tail | 1 | 2001 | 11 | 0.040 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2021 | 30 | 0.040 |
Why?
|
| Salpingo-oophorectomy | 1 | 2020 | 10 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2003 | 511 | 0.040 |
Why?
|
| Breast Neoplasms | 3 | 2011 | 2602 | 0.040 |
Why?
|
| Lim Kinases | 1 | 2020 | 7 | 0.040 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2005 | 401 | 0.040 |
Why?
|
| Fetal Heart | 1 | 2002 | 132 | 0.040 |
Why?
|
| Heterografts | 1 | 2021 | 191 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2014 | 801 | 0.040 |
Why?
|
| Ventricular Remodeling | 1 | 2001 | 155 | 0.040 |
Why?
|
| RNA, Neoplasm | 1 | 2000 | 125 | 0.040 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2020 | 17 | 0.040 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 2020 | 18 | 0.040 |
Why?
|
| G2 Phase | 1 | 2000 | 39 | 0.040 |
Why?
|
| Insurance Claim Review | 1 | 2020 | 27 | 0.040 |
Why?
|
| Giant Cells | 2 | 2013 | 33 | 0.040 |
Why?
|
| Ectoderm | 1 | 2020 | 33 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 1998 | 252 | 0.040 |
Why?
|
| Genes, myc | 1 | 2000 | 96 | 0.040 |
Why?
|
| Androgens | 2 | 2014 | 247 | 0.040 |
Why?
|
| Pregnancy, Tubal | 1 | 2020 | 4 | 0.040 |
Why?
|
| Antimetabolites | 1 | 2020 | 27 | 0.040 |
Why?
|
| Oxygen | 1 | 2003 | 548 | 0.040 |
Why?
|
| Cyclin D1 | 1 | 2000 | 106 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2000 | 587 | 0.040 |
Why?
|
| Inhibins | 1 | 2000 | 82 | 0.040 |
Why?
|
| In Vitro Techniques | 3 | 2009 | 808 | 0.040 |
Why?
|
| Heart Ventricles | 5 | 2005 | 749 | 0.040 |
Why?
|
| Calcitriol | 2 | 1997 | 63 | 0.040 |
Why?
|
| Sexual Behavior, Animal | 2 | 1996 | 53 | 0.040 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2019 | 8 | 0.040 |
Why?
|
| Troponin | 1 | 2000 | 69 | 0.040 |
Why?
|
| Heart | 3 | 2001 | 650 | 0.040 |
Why?
|
| Trachea | 1 | 2001 | 209 | 0.040 |
Why?
|
| Blotting, Southern | 3 | 2012 | 203 | 0.040 |
Why?
|
| Aquaporins | 1 | 2019 | 11 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 2121 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2002 | 450 | 0.040 |
Why?
|
| Thymus Gland | 1 | 1999 | 104 | 0.040 |
Why?
|
| Neuroendocrine Tumors | 1 | 2000 | 70 | 0.040 |
Why?
|
| Luciferases | 3 | 2006 | 127 | 0.040 |
Why?
|
| Colforsin | 2 | 2010 | 45 | 0.040 |
Why?
|
| Matrix Metalloproteinases | 2 | 2014 | 62 | 0.040 |
Why?
|
| Transplantation Tolerance | 1 | 2019 | 11 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2019 | 67 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2019 | 57 | 0.040 |
Why?
|
| Age Factors | 3 | 2017 | 2825 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2000 | 200 | 0.040 |
Why?
|
| Collagen | 4 | 2001 | 273 | 0.040 |
Why?
|
| Hindlimb Suspension | 1 | 1998 | 16 | 0.040 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1999 | 110 | 0.040 |
Why?
|
| Genetic Pleiotropy | 1 | 2018 | 25 | 0.040 |
Why?
|
| Information Dissemination | 1 | 2021 | 194 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2000 | 312 | 0.040 |
Why?
|
| EGF Family of Proteins | 2 | 2010 | 12 | 0.040 |
Why?
|
| Amphiregulin | 2 | 2010 | 13 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2020 | 700 | 0.030 |
Why?
|
| Nuclear Receptor Subfamily 6, Group A, Member 1 | 3 | 2003 | 7 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2001 | 502 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2019 | 84 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2019 | 85 | 0.030 |
Why?
|
| Weight-Bearing | 1 | 1998 | 49 | 0.030 |
Why?
|
| Doxycycline | 2 | 2010 | 112 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2018 | 26 | 0.030 |
Why?
|
| Flagella | 2 | 2009 | 27 | 0.030 |
Why?
|
| Incidence | 2 | 2020 | 3360 | 0.030 |
Why?
|
| COUP Transcription Factor I | 3 | 2010 | 54 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2018 | 154 | 0.030 |
Why?
|
| Genitalia, Male | 1 | 1998 | 33 | 0.030 |
Why?
|
| Carbon Isotopes | 1 | 2018 | 227 | 0.030 |
Why?
|
| alpha 1-Antitrypsin | 2 | 1989 | 81 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2000 | 1046 | 0.030 |
Why?
|
| Glossopharyngeal Nerve | 1 | 1997 | 5 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2018 | 142 | 0.030 |
Why?
|
| Ganglia | 1 | 1997 | 13 | 0.030 |
Why?
|
| Biopsy | 1 | 2021 | 1239 | 0.030 |
Why?
|
| Medicaid | 1 | 2020 | 268 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 106 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 1997 | 43 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2018 | 332 | 0.030 |
Why?
|
| Gene Library | 2 | 1998 | 212 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2018 | 101 | 0.030 |
Why?
|
| Maternal Age | 1 | 2017 | 136 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 155 | 0.030 |
Why?
|
| RNA | 4 | 2004 | 517 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2018 | 317 | 0.030 |
Why?
|
| Sequence Deletion | 2 | 2002 | 516 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 1011 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2000 | 362 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 633 | 0.030 |
Why?
|
| Sex Characteristics | 2 | 2015 | 323 | 0.030 |
Why?
|
| Thyroid Nuclear Factor 1 | 1 | 1996 | 9 | 0.030 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1997 | 137 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2018 | 197 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2000 | 357 | 0.030 |
Why?
|
| Lung Injury | 1 | 1998 | 126 | 0.030 |
Why?
|
| Osteoblasts | 2 | 1997 | 175 | 0.030 |
Why?
|
| Chorion | 1 | 2016 | 16 | 0.030 |
Why?
|
| Glucokinase | 1 | 2015 | 13 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2018 | 338 | 0.030 |
Why?
|
| Immunologic Surveillance | 1 | 2015 | 14 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2001 | 872 | 0.030 |
Why?
|
| Prognosis | 2 | 2020 | 4886 | 0.030 |
Why?
|
| Molecular Weight | 2 | 2012 | 276 | 0.030 |
Why?
|
| Organogenesis | 1 | 2016 | 75 | 0.030 |
Why?
|
| Dimerization | 2 | 2007 | 137 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2009 | 410 | 0.030 |
Why?
|
| Hormone Antagonists | 2 | 2008 | 43 | 0.030 |
Why?
|
| Dopamine | 1 | 1996 | 246 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2019 | 487 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 1996 | 150 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2015 | 43 | 0.030 |
Why?
|
| Sertoli Cells | 1 | 2015 | 73 | 0.030 |
Why?
|
| Placental Circulation | 1 | 2015 | 23 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 156 | 0.030 |
Why?
|
| Noise | 1 | 2015 | 17 | 0.030 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 1996 | 75 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2015 | 25 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2015 | 308 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 3436 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 149 | 0.030 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 1995 | 99 | 0.030 |
Why?
|
| Smad2 Protein | 1 | 2014 | 54 | 0.030 |
Why?
|
| Adenosine Triphosphate | 2 | 2007 | 265 | 0.030 |
Why?
|
| Multiple Sclerosis | 1 | 2018 | 395 | 0.030 |
Why?
|
| Cricetinae | 2 | 2006 | 362 | 0.030 |
Why?
|
| Saimiri | 3 | 1983 | 11 | 0.030 |
Why?
|
| Kidney | 2 | 2000 | 1282 | 0.030 |
Why?
|
| Diencephalon | 1 | 1994 | 7 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2014 | 34 | 0.030 |
Why?
|
| Risk Factors | 2 | 2020 | 11074 | 0.030 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2014 | 87 | 0.030 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2014 | 16 | 0.030 |
Why?
|
| Axons | 1 | 1997 | 386 | 0.030 |
Why?
|
| Tissue Distribution | 3 | 2003 | 358 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2014 | 63 | 0.030 |
Why?
|
| Ovalbumin | 1 | 1994 | 114 | 0.030 |
Why?
|
| Arginase | 1 | 2014 | 34 | 0.030 |
Why?
|
| CLOCK Proteins | 1 | 2014 | 33 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2015 | 208 | 0.030 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2014 | 45 | 0.030 |
Why?
|
| Activins | 1 | 2013 | 72 | 0.030 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2013 | 22 | 0.030 |
Why?
|
| Biological Evolution | 1 | 2015 | 222 | 0.020 |
Why?
|
| Tight Junction Proteins | 1 | 2013 | 14 | 0.020 |
Why?
|
| Hernia, Diaphragmatic | 2 | 2005 | 91 | 0.020 |
Why?
|
| Angiopoietins | 1 | 2013 | 18 | 0.020 |
Why?
|
| Egg Proteins | 2 | 2003 | 30 | 0.020 |
Why?
|
| Genes, APC | 1 | 2013 | 13 | 0.020 |
Why?
|
| Cervix Uteri | 1 | 2013 | 57 | 0.020 |
Why?
|
| United States | 2 | 2020 | 12072 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 300 | 0.020 |
Why?
|
| Plasmids | 3 | 1993 | 449 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1993 | 330 | 0.020 |
Why?
|
| Aromatase Inhibitors | 1 | 2013 | 81 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2013 | 123 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2014 | 299 | 0.020 |
Why?
|
| Azo Compounds | 1 | 2012 | 14 | 0.020 |
Why?
|
| Leiomyoma | 1 | 2013 | 71 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2012 | 64 | 0.020 |
Why?
|
| Mice, Inbred C3H | 2 | 2006 | 95 | 0.020 |
Why?
|
| Calmodulin | 1 | 1993 | 212 | 0.020 |
Why?
|
| Smoking | 1 | 2018 | 932 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2014 | 232 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 1992 | 110 | 0.020 |
Why?
|
| alpha Catenin | 1 | 2012 | 7 | 0.020 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2012 | 17 | 0.020 |
Why?
|
| Occludin | 1 | 2012 | 19 | 0.020 |
Why?
|
| Weight Gain | 1 | 2015 | 393 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2012 | 36 | 0.020 |
Why?
|
| Neprilysin | 1 | 2012 | 16 | 0.020 |
Why?
|
| Interleukin-15 | 1 | 2013 | 104 | 0.020 |
Why?
|
| Particle Size | 1 | 2012 | 135 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2014 | 410 | 0.020 |
Why?
|
| Claudins | 1 | 2012 | 29 | 0.020 |
Why?
|
| Antigens | 2 | 1983 | 105 | 0.020 |
Why?
|
| Motor Activity | 1 | 2015 | 489 | 0.020 |
Why?
|
| Tight Junctions | 1 | 2012 | 40 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2013 | 197 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2002 | 8635 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2012 | 86 | 0.020 |
Why?
|
| Organ Size | 3 | 1999 | 407 | 0.020 |
Why?
|
| Neutrophils | 1 | 2014 | 371 | 0.020 |
Why?
|
| Casein Kinase Ialpha | 1 | 2011 | 4 | 0.020 |
Why?
|
| Lactation | 2 | 2010 | 195 | 0.020 |
Why?
|
| Wnt-5a Protein | 1 | 2011 | 23 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 135 | 0.020 |
Why?
|
| Genotyping Techniques | 1 | 2012 | 110 | 0.020 |
Why?
|
| STAT5 Transcription Factor | 1 | 2012 | 93 | 0.020 |
Why?
|
| Urogenital Neoplasms | 1 | 1991 | 11 | 0.020 |
Why?
|
| Sirolimus | 1 | 2013 | 230 | 0.020 |
Why?
|
| Bronchial Neoplasms | 1 | 1991 | 15 | 0.020 |
Why?
|
| Fetus | 1 | 2015 | 568 | 0.020 |
Why?
|
| Sulfonylurea Receptors | 2 | 2002 | 12 | 0.020 |
Why?
|
| ADAMTS4 Protein | 1 | 2011 | 9 | 0.020 |
Why?
|
| Codon | 1 | 2011 | 93 | 0.020 |
Why?
|
| Perfusion | 2 | 2003 | 209 | 0.020 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2011 | 26 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 631 | 0.020 |
Why?
|
| Goblet Cells | 1 | 2012 | 105 | 0.020 |
Why?
|
| Cryopreservation | 1 | 1991 | 79 | 0.020 |
Why?
|
| Growth Hormone | 2 | 2005 | 130 | 0.020 |
Why?
|
| Neurons | 3 | 2015 | 1979 | 0.020 |
Why?
|
| Chimera | 2 | 2005 | 79 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2012 | 585 | 0.020 |
Why?
|
| Mucin-1 | 1 | 2011 | 32 | 0.020 |
Why?
|
| Metallothionein | 2 | 2003 | 16 | 0.020 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2011 | 57 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 5063 | 0.020 |
Why?
|
| Diethylstilbestrol | 1 | 2010 | 39 | 0.020 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2010 | 13 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 1410 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2012 | 576 | 0.020 |
Why?
|
| Kinetics | 2 | 2002 | 1088 | 0.020 |
Why?
|
| Chickens | 3 | 1997 | 267 | 0.020 |
Why?
|
| Parity | 1 | 2010 | 77 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 136 | 0.020 |
Why?
|
| Genes, jun | 1 | 2010 | 6 | 0.020 |
Why?
|
| Steroid Hydroxylases | 1 | 2010 | 19 | 0.020 |
Why?
|
| Protein Stability | 1 | 2010 | 165 | 0.020 |
Why?
|
| Glomerular Mesangium | 2 | 2000 | 19 | 0.020 |
Why?
|
| Cadherins | 1 | 2011 | 182 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2000 | 40 | 0.020 |
Why?
|
| Complement C3 | 2 | 2000 | 44 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2011 | 729 | 0.020 |
Why?
|
| Obesity | 2 | 2015 | 2426 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2014 | 713 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2009 | 47 | 0.020 |
Why?
|
| Hematuria | 2 | 2000 | 48 | 0.020 |
Why?
|
| Pancreatitis-Associated Proteins | 1 | 2009 | 15 | 0.020 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2009 | 20 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2002 | 1105 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2011 | 450 | 0.020 |
Why?
|
| Feces | 1 | 2012 | 721 | 0.020 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2008 | 11 | 0.020 |
Why?
|
| Gonanes | 1 | 2008 | 13 | 0.020 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2008 | 22 | 0.020 |
Why?
|
| Connexin 43 | 1 | 2008 | 34 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2015 | 1077 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2008 | 66 | 0.020 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 10 | 0.020 |
Why?
|
| Liver Neoplasms | 2 | 2010 | 1373 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2008 | 23 | 0.020 |
Why?
|
| Nitrobenzenes | 1 | 2008 | 10 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2008 | 56 | 0.020 |
Why?
|
| Caseins | 1 | 1988 | 65 | 0.020 |
Why?
|
| Splenic Neoplasms | 1 | 2007 | 12 | 0.020 |
Why?
|
| Gonadotropins | 1 | 2008 | 31 | 0.020 |
Why?
|
| Trefoil Factor-1 | 1 | 2007 | 5 | 0.020 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2007 | 16 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2012 | 791 | 0.020 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2007 | 27 | 0.020 |
Why?
|
| Luciferases, Firefly | 1 | 2007 | 11 | 0.020 |
Why?
|
| Indomethacin | 1 | 2008 | 79 | 0.020 |
Why?
|
| Anilides | 1 | 2008 | 52 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 95 | 0.020 |
Why?
|
| Cell Shape | 1 | 2007 | 67 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2000 | 765 | 0.020 |
Why?
|
| Urologic Neoplasms | 1 | 2007 | 30 | 0.020 |
Why?
|
| Genes, myb | 1 | 2007 | 2 | 0.020 |
Why?
|
| Brain | 3 | 1994 | 3175 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2007 | 32 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2007 | 36 | 0.020 |
Why?
|
| Thymus Neoplasms | 1 | 2007 | 39 | 0.020 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2007 | 25 | 0.020 |
Why?
|
| Transformation, Genetic | 1 | 1987 | 27 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 189 | 0.020 |
Why?
|
| Genes, erbB-2 | 1 | 2007 | 32 | 0.020 |
Why?
|
| Gene Components | 1 | 2006 | 7 | 0.020 |
Why?
|
| Genes, Viral | 1 | 1987 | 155 | 0.020 |
Why?
|
| Zona Pellucida Glycoproteins | 2 | 2003 | 8 | 0.020 |
Why?
|
| Helix-Loop-Helix Motifs | 2 | 1997 | 29 | 0.020 |
Why?
|
| Malonyl Coenzyme A | 1 | 2006 | 4 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2007 | 157 | 0.020 |
Why?
|
| Heart Neoplasms | 1 | 2007 | 106 | 0.020 |
Why?
|
| Mesocricetus | 1 | 2006 | 65 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 246 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2007 | 414 | 0.010 |
Why?
|
| Xenopus | 1 | 2006 | 102 | 0.010 |
Why?
|
| Animal Feed | 1 | 2006 | 82 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2007 | 166 | 0.010 |
Why?
|
| Duodenum | 1 | 2006 | 111 | 0.010 |
Why?
|
| STAT6 Transcription Factor | 1 | 2005 | 34 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 292 | 0.010 |
Why?
|
| Posture | 2 | 1996 | 138 | 0.010 |
Why?
|
| Growth | 1 | 2006 | 93 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2006 | 241 | 0.010 |
Why?
|
| Spine | 1 | 2006 | 153 | 0.010 |
Why?
|
| Puberty, Delayed | 1 | 2005 | 5 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2008 | 296 | 0.010 |
Why?
|
| Neuropilin-1 | 1 | 2005 | 14 | 0.010 |
Why?
|
| Embryonic Induction | 1 | 2005 | 16 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 2005 | 126 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 2005 | 81 | 0.010 |
Why?
|
| Glucagon | 1 | 2005 | 146 | 0.010 |
Why?
|
| C-Peptide | 1 | 2005 | 107 | 0.010 |
Why?
|
| Adenosine Monophosphate | 1 | 2004 | 47 | 0.010 |
Why?
|
| Dietary Fats | 1 | 2006 | 278 | 0.010 |
Why?
|
| Diaphragm | 1 | 2005 | 101 | 0.010 |
Why?
|
| Mucin 5AC | 1 | 2004 | 23 | 0.010 |
Why?
|
| Genes, Synthetic | 2 | 1995 | 13 | 0.010 |
Why?
|
| Mucus | 1 | 2004 | 37 | 0.010 |
Why?
|
| Bone and Bones | 2 | 1997 | 308 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2006 | 775 | 0.010 |
Why?
|
| Receptors, Calcitonin | 1 | 2004 | 21 | 0.010 |
Why?
|
| Cathepsin L | 1 | 2003 | 9 | 0.010 |
Why?
|
| Growth Disorders | 1 | 2005 | 181 | 0.010 |
Why?
|
| Hypertrophy | 2 | 1995 | 100 | 0.010 |
Why?
|
| Baculoviridae | 1 | 2003 | 41 | 0.010 |
Why?
|
| Arteries | 1 | 2005 | 208 | 0.010 |
Why?
|
| Skull | 2 | 1997 | 149 | 0.010 |
Why?
|
| Cathepsins | 1 | 2003 | 24 | 0.010 |
Why?
|
| Insecta | 1 | 2003 | 45 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2003 | 64 | 0.010 |
Why?
|
| Keratinocytes | 1 | 2004 | 71 | 0.010 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2003 | 16 | 0.010 |
Why?
|
| Cilia | 1 | 2004 | 74 | 0.010 |
Why?
|
| Point Mutation | 1 | 2004 | 333 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2005 | 435 | 0.010 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2004 | 135 | 0.010 |
Why?
|
| Nucleoplasmins | 1 | 2003 | 3 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 405 | 0.010 |
Why?
|
| CHO Cells | 1 | 2003 | 152 | 0.010 |
Why?
|
| Glycoprotein Hormones, alpha Subunit | 1 | 2003 | 5 | 0.010 |
Why?
|
| Thecoma | 1 | 2003 | 3 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2003 | 79 | 0.010 |
Why?
|
| Cebidae | 1 | 1983 | 4 | 0.010 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2003 | 27 | 0.010 |
Why?
|
| Leydig Cells | 1 | 2003 | 21 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2003 | 110 | 0.010 |
Why?
|
| Octreotide | 1 | 2003 | 23 | 0.010 |
Why?
|
| Fertilization | 1 | 2003 | 44 | 0.010 |
Why?
|
| Spindle Apparatus | 1 | 2003 | 50 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2006 | 387 | 0.010 |
Why?
|
| Oogenesis | 1 | 2003 | 50 | 0.010 |
Why?
|
| Nerve Crush | 1 | 2002 | 8 | 0.010 |
Why?
|
| Meiosis | 1 | 2003 | 111 | 0.010 |
Why?
|
| Embryo Loss | 1 | 2002 | 20 | 0.010 |
Why?
|
| Body Constitution | 1 | 2002 | 42 | 0.010 |
Why?
|
| Yolk Sac | 1 | 2002 | 11 | 0.010 |
Why?
|
| Cyclin T | 1 | 2002 | 31 | 0.010 |
Why?
|
| Acetylation | 1 | 2003 | 190 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2002 | 32 | 0.010 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2002 | 36 | 0.010 |
Why?
|
| Superovulation | 1 | 2002 | 11 | 0.010 |
Why?
|
| rho-Specific Guanine Nucleotide Dissociation Inhibitors | 1 | 2002 | 7 | 0.010 |
Why?
|
| rho Guanine Nucleotide Dissociation Inhibitor alpha | 1 | 2002 | 9 | 0.010 |
Why?
|
| Peripheral Nerves | 1 | 2002 | 91 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 468 | 0.010 |
Why?
|
| Seminal Vesicles | 1 | 2002 | 51 | 0.010 |
Why?
|
| Fertilization in Vitro | 1 | 1983 | 155 | 0.010 |
Why?
|
| Vas Deferens | 1 | 2002 | 21 | 0.010 |
Why?
|
| Spleen | 1 | 2003 | 258 | 0.010 |
Why?
|
| Urogenital System | 1 | 2002 | 33 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2003 | 686 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 17753 | 0.010 |
Why?
|
| Radioimmunoassay | 2 | 1997 | 82 | 0.010 |
Why?
|
| Myofibrils | 1 | 2001 | 24 | 0.010 |
Why?
|
| Lipoprotein Lipase | 1 | 2001 | 60 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2001 | 20 | 0.010 |
Why?
|
| Immunization | 1 | 1983 | 269 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1981 | 158 | 0.010 |
Why?
|
| Somites | 1 | 2001 | 8 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2003 | 579 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 2001 | 85 | 0.010 |
Why?
|
| RNA, Long Noncoding | 1 | 2003 | 218 | 0.010 |
Why?
|
| Cocarcinogenesis | 1 | 2000 | 15 | 0.010 |
Why?
|
| Nocodazole | 1 | 2000 | 11 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2006 | 668 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2006 | 970 | 0.010 |
Why?
|
| Neurosecretory Systems | 1 | 2000 | 22 | 0.010 |
Why?
|
| Checkpoint Kinase 1 | 1 | 2000 | 26 | 0.010 |
Why?
|
| Biological Transport | 1 | 2001 | 329 | 0.010 |
Why?
|
| Chaperonins | 1 | 2000 | 15 | 0.010 |
Why?
|
| Radionuclide Angiography | 1 | 2000 | 2 | 0.010 |
Why?
|
| Gamma Rays | 1 | 2000 | 38 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2001 | 436 | 0.010 |
Why?
|
| Tantalum | 1 | 2000 | 7 | 0.010 |
Why?
|
| Sulfonylurea Compounds | 1 | 2000 | 20 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2000 | 53 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2002 | 373 | 0.010 |
Why?
|
| Hyperlipidemias | 1 | 2001 | 185 | 0.010 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2000 | 94 | 0.010 |
Why?
|
| Synaptophysin | 1 | 2000 | 17 | 0.010 |
Why?
|
| Antineoplastic Agents | 2 | 2000 | 1826 | 0.010 |
Why?
|
| Microinjections | 2 | 1991 | 38 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 1999 | 16 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 2003 | 494 | 0.010 |
Why?
|
| Transplantation Chimera | 1 | 1999 | 44 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 1999 | 52 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2000 | 192 | 0.010 |
Why?
|
| Hydroxyurea | 1 | 2000 | 89 | 0.010 |
Why?
|
| Embryo Transfer | 2 | 1991 | 48 | 0.010 |
Why?
|
| S Phase | 1 | 1999 | 76 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2000 | 166 | 0.010 |
Why?
|
| Fatty Liver | 1 | 2001 | 224 | 0.010 |
Why?
|
| G1 Phase | 1 | 1999 | 68 | 0.010 |
Why?
|
| Testicular Neoplasms | 1 | 2000 | 112 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2001 | 587 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2000 | 293 | 0.010 |
Why?
|
| Infertility, Male | 1 | 2002 | 296 | 0.010 |
Why?
|
| DNA Probes | 1 | 1998 | 117 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2000 | 743 | 0.010 |
Why?
|
| Hypoglycemia | 1 | 2000 | 190 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 2596 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2007 | 1306 | 0.010 |
Why?
|
| Follistatin | 1 | 1998 | 37 | 0.010 |
Why?
|
| Atrophy | 1 | 1998 | 247 | 0.010 |
Why?
|
| Secretin | 1 | 1997 | 12 | 0.010 |
Why?
|
| Cholecystokinin | 1 | 1997 | 11 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1997 | 117 | 0.010 |
Why?
|
| RNA Splicing | 1 | 1999 | 235 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 1997 | 72 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1998 | 242 | 0.010 |
Why?
|
| Ribonucleases | 1 | 1997 | 43 | 0.010 |
Why?
|
| Reference Values | 1 | 1998 | 676 | 0.010 |
Why?
|
| Neural Crest | 1 | 1997 | 52 | 0.010 |
Why?
|
| Peptides | 1 | 2000 | 708 | 0.010 |
Why?
|
| DNA Repair | 1 | 2000 | 571 | 0.010 |
Why?
|
| DNA Damage | 1 | 2000 | 511 | 0.010 |
Why?
|
| Rhombencephalon | 1 | 1997 | 63 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1996 | 140 | 0.010 |
Why?
|
| Human Growth Hormone | 1 | 1997 | 74 | 0.010 |
Why?
|
| Endometritis | 1 | 1996 | 9 | 0.010 |
Why?
|
| Copulation | 1 | 1995 | 7 | 0.010 |
Why?
|
| Neuroimmunomodulation | 1 | 1996 | 18 | 0.010 |
Why?
|
| Serotonin | 1 | 1996 | 208 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2001 | 2304 | 0.010 |
Why?
|
| Cell Fusion | 1 | 1995 | 32 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1996 | 426 | 0.010 |
Why?
|
| RNA Probes | 1 | 1994 | 25 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 1995 | 190 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1994 | 198 | 0.010 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1993 | 45 | 0.010 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 1992 | 33 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 1992 | 45 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1993 | 305 | 0.010 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 1992 | 33 | 0.010 |
Why?
|
| Pheochromocytoma | 1 | 1992 | 31 | 0.010 |
Why?
|
| Femur | 1 | 1993 | 79 | 0.010 |
Why?
|
| Tretinoin | 1 | 1993 | 95 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1997 | 477 | 0.010 |
Why?
|
| Nerve Growth Factors | 1 | 1992 | 65 | 0.010 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1992 | 64 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1991 | 71 | 0.010 |
Why?
|
| Multigene Family | 1 | 1992 | 290 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1999 | 1722 | 0.010 |
Why?
|
| Heart Atria | 1 | 1993 | 343 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2001 | 6459 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1991 | 295 | 0.000 |
Why?
|
| Action Potentials | 1 | 1992 | 476 | 0.000 |
Why?
|
| Liver Cirrhosis, Experimental | 1 | 1989 | 5 | 0.000 |
Why?
|
| Necrosis | 1 | 1989 | 192 | 0.000 |
Why?
|
| Neoplasms | 1 | 2003 | 3016 | 0.000 |
Why?
|
| Bovine papillomavirus 1 | 1 | 1987 | 8 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1987 | 73 | 0.000 |
Why?
|
| Bucladesine | 1 | 1983 | 18 | 0.000 |
Why?
|
| Autoradiography | 1 | 1983 | 61 | 0.000 |
Why?
|
| Chromosomes | 1 | 1983 | 120 | 0.000 |
Why?
|
| Culture Media | 1 | 1983 | 171 | 0.000 |
Why?
|
| Antibody Affinity | 1 | 1983 | 37 | 0.000 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1983 | 92 | 0.000 |
Why?
|
| Antibody Formation | 1 | 1983 | 227 | 0.000 |
Why?
|
| Chromosome Aberrations | 1 | 1983 | 573 | 0.000 |
Why?
|